Friday 25th March 2022
New treatment which prevents COVID-19 infection in immunocompromised adults approved in UK
On the 17th March 2022 the UK’s Medicine and Health products Regulation Agency (MHRA) approved a new drug, Evusheld, for the prevention of COVID-19 infection.